WO2003023406A3 - Diagnostic method for transmissible spongiform encephalopathies - Google Patents
Diagnostic method for transmissible spongiform encephalopathies Download PDFInfo
- Publication number
- WO2003023406A3 WO2003023406A3 PCT/EP2002/010063 EP0210063W WO03023406A3 WO 2003023406 A3 WO2003023406 A3 WO 2003023406A3 EP 0210063 W EP0210063 W EP 0210063W WO 03023406 A3 WO03023406 A3 WO 03023406A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- transmissible spongiform
- diagnostic method
- spongiform encephalopathies
- tse
- polypeptide
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2828—Prion diseases
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002459500A CA2459500A1 (en) | 2001-09-05 | 2002-09-03 | Diagnostic method for transmissible spongiform encephalopathies |
AU2002331112A AU2002331112B2 (en) | 2001-09-05 | 2002-09-03 | Diagnostic method for transmissible spongiform encephalopathies |
EP02767478A EP1423703A2 (en) | 2001-09-05 | 2002-09-03 | Diagnostic method for transmissible spongiform encephalopathies |
JP2003527426A JP4312049B2 (en) | 2001-09-05 | 2002-09-03 | Test method for use in the diagnosis of infectious spongiform encephalopathy |
US10/695,194 US20040171026A1 (en) | 2001-09-05 | 2003-10-28 | Diagnostic method for transmissible spongiform encephalopathies |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0121459.2 | 2001-09-05 | ||
GB0121459A GB2379737A (en) | 2001-09-05 | 2001-09-05 | Diagnostic method for spongiform encephalopathy disease |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/695,194 Continuation-In-Part US20040171026A1 (en) | 2001-09-05 | 2003-10-28 | Diagnostic method for transmissible spongiform encephalopathies |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2003023406A2 WO2003023406A2 (en) | 2003-03-20 |
WO2003023406A3 true WO2003023406A3 (en) | 2003-11-27 |
WO2003023406A9 WO2003023406A9 (en) | 2004-02-26 |
Family
ID=9921541
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/010063 WO2003023406A2 (en) | 2001-09-05 | 2002-09-03 | Diagnostic method for transmissible spongiform encephalopathies |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1423703A2 (en) |
JP (1) | JP4312049B2 (en) |
AU (1) | AU2002331112B2 (en) |
CA (1) | CA2459500A1 (en) |
GB (1) | GB2379737A (en) |
WO (1) | WO2003023406A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1556702A2 (en) * | 2002-10-30 | 2005-07-27 | Proteome Sciences Plc | Diagnostic methods for transmissible spongiform encephalopathies (prion diseases) |
CN114324557A (en) * | 2021-12-03 | 2022-04-12 | 融智生物科技(青岛)有限公司 | Zeta-globin detection method based on MALDI-TOF MS |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998026293A1 (en) * | 1996-12-12 | 1998-06-18 | Neuromark | Methods of detecting transmissible spongiform encephalopathies by detecting 14-3-3 protein isoforms |
WO2000078344A1 (en) * | 1999-06-23 | 2000-12-28 | Caprion Pharmaceuticals, Inc. | Prion protein peptides and uses thereof |
WO2001025791A2 (en) * | 1999-10-07 | 2001-04-12 | Ciphergen Biosystems, Inc. | Prostate cancer marker proteins |
US6225047B1 (en) * | 1997-06-20 | 2001-05-01 | Ciphergen Biosystems, Inc. | Use of retentate chromatography to generate difference maps |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19918141A1 (en) * | 1999-04-21 | 2000-10-26 | Boehringer Ingelheim Vetmed | Diagnosing transmissible spongiform encephalopathy, particularly before appearance of clinical symptoms, by detecting specific markers in blood cells |
DE19923811C1 (en) * | 1999-05-20 | 2000-12-07 | Robert Koch Inst | Procedure for the diagnosis of TSE-induced changes in tissues using infrared spectroscopy |
GB2360089A (en) * | 2000-03-10 | 2001-09-12 | Univ Geneve | Diagnostic assay for transmisible spongiform encephalopathies |
-
2001
- 2001-09-05 GB GB0121459A patent/GB2379737A/en not_active Withdrawn
-
2002
- 2002-09-03 EP EP02767478A patent/EP1423703A2/en not_active Withdrawn
- 2002-09-03 WO PCT/EP2002/010063 patent/WO2003023406A2/en active Application Filing
- 2002-09-03 AU AU2002331112A patent/AU2002331112B2/en not_active Ceased
- 2002-09-03 JP JP2003527426A patent/JP4312049B2/en not_active Expired - Fee Related
- 2002-09-03 CA CA002459500A patent/CA2459500A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998026293A1 (en) * | 1996-12-12 | 1998-06-18 | Neuromark | Methods of detecting transmissible spongiform encephalopathies by detecting 14-3-3 protein isoforms |
US6225047B1 (en) * | 1997-06-20 | 2001-05-01 | Ciphergen Biosystems, Inc. | Use of retentate chromatography to generate difference maps |
WO2000078344A1 (en) * | 1999-06-23 | 2000-12-28 | Caprion Pharmaceuticals, Inc. | Prion protein peptides and uses thereof |
WO2001025791A2 (en) * | 1999-10-07 | 2001-04-12 | Ciphergen Biosystems, Inc. | Prostate cancer marker proteins |
Also Published As
Publication number | Publication date |
---|---|
JP2005502882A (en) | 2005-01-27 |
AU2002331112B2 (en) | 2006-12-21 |
WO2003023406A9 (en) | 2004-02-26 |
CA2459500A1 (en) | 2003-03-20 |
EP1423703A2 (en) | 2004-06-02 |
JP4312049B2 (en) | 2009-08-12 |
WO2003023406A2 (en) | 2003-03-20 |
GB0121459D0 (en) | 2001-10-24 |
GB2379737A (en) | 2003-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2282825A1 (en) | Spectroscopic determination of characteristics of biological material | |
MY139241A (en) | Noninvasive blood pressure monitoring system | |
WO2001082793A3 (en) | Method and device for testing a sample of fresh whole blood | |
WO2002064031A3 (en) | Multidimensional eye tracking and position measurement system | |
WO2003015691A3 (en) | RAPID IMPROVEMENT OF COGNITION IN CONDITIONS RELATED TO A$g(b) | |
WO2003048735A3 (en) | Processes for the measurement of the potency of glatiramer acetate | |
BR0206604A (en) | Lancet device that has capillary action | |
WO2001094941A3 (en) | Diagnostic methods for pompe disease and other glycogen storage diseases | |
WO2002081513A3 (en) | Disease-associated protein | |
CA2356442A1 (en) | Nmr spectroscopic in vitro assay using hyperpolarization | |
WO2001057537A3 (en) | Methods for diagnosis of alzheimer's disease | |
WO2003023406A3 (en) | Diagnostic method for transmissible spongiform encephalopathies | |
WO2002084246A3 (en) | Leak indicator with test leak and test leak for integration into a leak indicator | |
WO2002089656A3 (en) | Diagnosis of acute myocardial infarction | |
WO2002077012A3 (en) | Human papilloma virus immunoreative peptides | |
WO2003084384A3 (en) | Diagnosis of flavivirus infection | |
WO2002071028A3 (en) | X-ray phase contrast imaging using a fabry-perot interferometer concept | |
WO2007015177A8 (en) | In vitro diagnostic method and kit for an aspergillus infection | |
Ødegard et al. | Fatigue properties of an A 356(AlSi 7 Mg) aluminum alloy for automotive applications: Fatigue life prediction | |
CA2434879A1 (en) | Test for transmissible spongiform encephalopathies | |
WO2004040316A3 (en) | Diagnostic method for transmissible spongiform encephalopathies (prion diseases) | |
WO2002059600A3 (en) | Analyte detection | |
WO2003069346A3 (en) | Diagnostic method for stroke | |
WO2002077636A3 (en) | Volatile signature detector and associated methods | |
WO2003086563A3 (en) | Diabetes imaging probes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG US |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10695194 Country of ref document: US |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/14-14/14, DRAWINGS, REPLACED BY NEW PAGES 1/30-30/30 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002767478 Country of ref document: EP Ref document number: 2002331112 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003527426 Country of ref document: JP Ref document number: 2459500 Country of ref document: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 2002767478 Country of ref document: EP |